Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03407781 : IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade Glioma
PhaseEarly Phase 1
AgesMin: 18 Years Max: 70 Years
Eligibility
Inclusion Criteria:

- Must be able to provide a written informed consent

- suspected lower grade gliomas on contrast-enhanced MRI

Exclusion Criteria:

- Consisted of conditions of mental illness

- Severe liver or kidney disease with serum creatinine > 3.0 mg/dl (270 µ?)

- Any hepatic enzyme level 5 times or more than normal upper limit

- Severe allergy or hypersensitivity to IV radiographic contrast

- Claustrophobia to accept the PET/CT or PET/MRI scanning

- Pregnancy or breast feeding
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03407781      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740